🔍
Search Results - john+abraham
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Specific Delivery of a Tumor-ablating Agent by a DECApeptide to Colon and Esophageal Cancer Cell Lines as a Therapeutic Treatment
C10039: Specific Delivery of a Tumor-ablating Agent by a DECApeptide to Colon and Esophageal Cancer Cell Lines as a Therapeutic TreatmentValue Proposition: The effectiveness of immunotherapeutic antibodies is limited by their relatively large size. This attribute results in the antibody attachment being limited to the exposed areas of a solid tumor....
Published: 6/27/2024
|
Inventor(s):
Stephen Meltzer
,
John Abraham
Keywords(s):
Biologics
,
Cancers
,
Colorectal Cancer
,
Disease Indication
,
Esophageal Cancer
,
Peptide
,
Single
,
Small Molecules
,
Targeted Therapy
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Ear, Nose & Throat
,
Clinical and Disease Specializations > Gastroenterology
,
Clinical and Disease Specializations > Oncology > Colorectal Cancer
,
Clinical and Disease Specializations > Oncology > Esophageal Cancer
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Peptides
,
Technology Classifications > Therapeutic Modalities > Targets
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum